Literature DB >> 30956268

Risk Factors and Prevalence of Deep Vein Thrombosis After the 2016 Kumamoto Earthquakes.

Koji Sato1, Kenji Sakamoto2, Yoichiro Hashimoto3, Kazuhiko Hanzawa4, Daisuke Sueta2, Sunao Kojima2, Masaya Fukuda1, Hiroki Usuku1, Fumie Kihara1, Hiroshi Hosokawa5, Yohei Nagai6, Makoto Nakajima7, Yoshiharu Saito1, Kayoko Sakai1, Sumio Masunaga8, Shinji Tanaka8, Kazuteru Fujimoto8, Kenji Morihisa9, Katsuo Noda9, Kazuhiro Nishigami8, Kohei Nagata8, Koichiro Fujisue2, Noriaki Tabata2, Yukio Ando7, Kenichi Tsujita2, Hisao Ogawa10, Seiji Hokimoto2.   

Abstract

BACKGROUND: After previous earthquakes, a high prevalence of deep vein thrombosis (DVT) has been reported. We examined DVT prevalence and risk factors in evacuees of the Kumamoto earthquakes by performing mobile DVT screening at various evacuation centers around the epicenter. Methods and 
Results: For 1 month after the Kumamoto earthquake on 14 April 2016, mobile DVT screening using portable ultrasonography (US) was performed at 80 evacuation centers. Questionnaires, physical examination, and US of the lower limb were carried out, and simple D-dimer measurements were undertaken for DVT-positive examinees. The total number of examinees was 1,673, of whom 178 (10.6%) had DVT. The prevalence of DVT seemed to be gradually decreasing in the screening period, but age, use of sleep medication, prevalence of hypertension, dyslipidemia, leg edema, and lower leg varix were significantly higher in the DVT positive group than in the negative group. On multivariable logistic regression analysis, high age (≥70 years old), use of sleep medication, lower leg edema, and lower leg varix were significant predictors of DVT. In examinees with these 4 predictors, the DVT positive rate was 71.4%.
CONCLUSIONS: In the first month after the Kumamoto earthquakes, DVT prevalence and severity, evaluated on D-dimer level, decreased with the passage of time. Mobile DVT screening indicated significant factors stratifying DVT risk in the evacuees.

Entities:  

Keywords:  Deep vein thrombosis; Disaster; Earthquake; Ultrasound; Venous thromboembolism

Year:  2019        PMID: 30956268     DOI: 10.1253/circj.CJ-18-1369

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Clinical characteristics of patients with ischemic stroke after the 2016 Kumamoto earthquake, a multi-center study.

Authors:  Yuichiro Inatomi; Makoto Nakajima; Tokunori Ikeda; Toshiro Yonehara; Tadashi Terasaki; Yoichiro Hashimoto; Yanosuke Kouzaki
Journal:  Neurol Sci       Date:  2021-03-20       Impact factor: 3.307

2.  MiR-205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression.

Authors:  Li-Li Sun; Lun Xiao; Xiao-Long Du; Lei Hong; Cheng-Long Li; Jian Jiao; Wen-Dong Li; Xiao-Qiang Li
Journal:  J Cell Mol Med       Date:  2019-10-21       Impact factor: 5.310

Review 3.  Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic.

Authors:  Keisuke Narita; Satoshi Hoshide; Kelvin Tsoi; Saulat Siddique; Jinho Shin; Yook-Chin Chia; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Chen-Huan Chen; Hao-Min Cheng; Guru Prasad Sogunuru; Tzung-Dau Wang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-01       Impact factor: 3.738

4.  FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice.

Authors:  Yan Meng; Qian Yin; Qiang Ma; Hao Qin; Junbo Zhang; Bo Zhang; Honggang Pang; Hongyan Tian
Journal:  Int J Mol Med       Date:  2021-03-24       Impact factor: 4.101

5.  Review on Disasters and Lower Limb Venous Disease.

Authors:  Sergio Gianesini; Erica Menegatti; Oscar Bottini; Yung-Wei Chi
Journal:  Ann Vasc Dis       Date:  2021-12-25

6.  Venous thrombosis in evacuees during war: Will the experience of our ancestors be put to good use?

Authors:  Daisuke Sueta; Kenichi Matsushita; Kenichi Tsujita
Journal:  Res Pract Thromb Haemost       Date:  2022-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.